Accreditation/Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Advances in™ Aplastic Anemia: Report from San Diego

Release Date: February 28, 2019
Expiration Date: June 12, 2020
Media: Internet - based

Activity Overview

This activity, Advances in™ Aplastic Anemia: Report from San Diego, developed in the Physicians’ Education Resource®, LLC, (PER®) established Advances in™ legacy format, will provide an overview of recent data in the diagnosis and management of aplastic anemia (AA). This update on emerging data will cover diagnostics in young and older adult patients, recent data on transplant options and outcomes, reconsiderations of transplantation in older patients, and advances in systemic therapy. Discussion will include emerging options that include the use of thrombopoietin receptor agonists alone or with conventional immunosuppressive therapy, and advances in understanding of clonal evolution in the context of emerging treatment options. New data will be discussed in the context of clinical practice from the perspective of Dr. Neal Young, a leading expert in the treatment of AA.

Benefits of Participating

  • Hear expert perspective on the potential for improved outcomes with transplantation in older patients with AA
  • Keep up-to-date with the latest emerging data for systemic therapy options for AA
  • Identify the role of emerging options in the context of improving care for your patients with AA

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Instructions for This Activity and Receiving Credit

  • You will need to log in to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review audio files/content until you finish the presentation.
  • At the end of the activity, educational content/audio files will be available for your reference.
  • In order to receive a CME/Ce certificate, you must complete the activity.
  • Complete the Posttest and pass with a score of 70% or higher, complete the Evaluation, and then click on “Request for Credit.” You may immediately download a CME/CE certificate upon completion of these steps.

Target Audience

This educational activity is directed toward hematologists and medical oncologists who treat patients with AA. Nurse practitioners, physician assistants, pharmacists, and other healthcare professionals interested in the treatment of AA are also invited to participate.

Learning Objectives

After successful completion of this activity, you should be better prepared to:

  • Discuss the pathologic characteristics of AA, the interplay between pathobiology and diagnosis, and the mechanistic characteristics of treatments for aplastic anemia
  • Detail strategies for first-line and second-line management of patients living with AA, as well as emerging options in the first-line setting
  • Determine strategies for recognizing and mitigating the impact of treatment-related adverse events in patients with AA
  • Contextualize the results of recent clinical trials as they apply to the evolving landscape of therapies for AA

Faculty, Staff, and Planners' Disclosures


Neal Young
Neal Young, MD
Editor, Seminars in Hematology
Master, American College of Physicians
Senior Investigator, National Institutes of Health
Bethesda, MD

Disclosures: Dr. Young participates in a Cooperative Research And Development Agreement (CRADA) with Novartis.

The staff of PER® have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME/Ce activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME/CE activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical and nursing education purposes only, and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any of the companies that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By